U.S. Markets closed
  • S&P 500

    3,855.36
    +13.89 (+0.36%)
     
  • Dow 30

    30,960.00
    -36.98 (-0.12%)
     
  • Nasdaq

    13,635.99
    +92.93 (+0.69%)
     
  • Russell 2000

    2,163.27
    -5.49 (-0.25%)
     
  • Crude Oil

    52.81
    +0.54 (+1.03%)
     
  • Gold

    1,854.70
    -1.50 (-0.08%)
     
  • Silver

    25.39
    -0.17 (-0.67%)
     
  • EUR/USD

    1.2146
    -0.0028 (-0.2308%)
     
  • 10-Yr Bond

    1.0400
    -0.0510 (-4.67%)
     
  • Vix

    23.19
    +1.28 (+5.84%)
     
  • GBP/USD

    1.3676
    -0.0008 (-0.0615%)
     
  • USD/JPY

    103.7640
    +0.0030 (+0.0029%)
     
  • BTC-USD

    32,546.33
    -900.91 (-2.69%)
     
  • CMC Crypto 200

    655.76
    -21.14 (-3.12%)
     
  • FTSE 100

    6,638.85
    -56.22 (-0.84%)
     
  • Nikkei 225

    28,822.29
    +190.84 (+0.67%)
     

Fujifilm expects clinical trial data on Avigan for COVID-19 in about a month

FILE PHOTO - Fujifilm's company logo is seen at its exhibition hall nearby the headquarters of Fujifilm Holdings Corp in Tokyo

TOKYO (Reuters) - Japan's Fujifilm Holdings Corp said on Thursday it expects data from a clinical trial of its Avigan drug on COVID-19 patients to be ready in about a month.

The last patient will enter the study on Aug. 16 and results will follow about a month after that, Fujifilm director Junji Okada said during a first-quarter earnings call.

The company will then work with Japanese regulators on submitting the drug for approval to treat COVID-19, he said.

(Reporting by Rocky Swift; Editing by Jan Harvey)